Penumbra, Inc. (NYSE: PEN) is set to present at the Canaccord Genuity Growth Conference on August 13, 2024. This leading thrombectomy company is dedicated to developing cutting-edge technologies for challenging medical conditions like ischemic stroke, venous thromboembolism, and acute limb ischemia. By removing blood clots from head-to-toe with speed, safety, and simplicity, Penumbra’s innovative portfolio, including computer assisted vacuum thrombectomy (CAVT), supports healthcare providers worldwide in improving patient outcomes and quality of life.
To access the webcast of Penumbra’s presentation at the conference, visit the “Events and Presentations” section under the “Investors” tab on the company’s website at http://www.penumbrainc.com. The webcast will be available for viewing on the website for at least two weeks following the event.
Penumbra’s commitment to advancing medical technologies has made it a trusted partner for healthcare providers, hospitals, and clinics in over 100 countries. For more information on Penumbra and its groundbreaking solutions, visit http://www.penumbrainc.com and follow the company on Instagram, LinkedIn, and X.
If you have any questions regarding Penumbra, Inc. or its investor relations, please reach out to the team at [email protected] Stay connected with Penumbra for the latest updates and advancements in medical technology.
For a look at the company’s logo, check out the image below:
[Include Image: https://mma.prnewswire.com/media/282131/penumbra_logo.jpg?p=original%5D
SOURCE Penumbra, Inc.
This summary highlights Penumbra, Inc.’s upcoming presentation at the Canaccord Genuity Growth Conference and its dedication to developing innovative technologies for challenging medical conditions. Stay informed on Penumbra’s progress by visiting their website and following them on social media.
Source link
